Subscribe
georgeclerk-1
georgeclerk / iStockphoto.com
27 September 2017Big Pharma

UK health committee to investigate pharma regulation after Brexit

The UK’s House of Commons has launched an investigation into post-Brexit regulatory agreements needed to guarantee the safe and effective supply of medicines and medical devices.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
House of Lords hears evidence on life sciences and Brexit
17 October 2017   The House of Lords is hearing from companies and regulators today on issues including the government’s life sciences strategy and Brexit’s impact on the industry.
Big Pharma
UK life sciences receives £160m government funding
30 August 2017   The UK government has committed £160 million ($280.2 million) in funding to the life sciences after a review of the industry.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Big Pharma
House of Lords hears evidence on life sciences and Brexit
17 October 2017   The House of Lords is hearing from companies and regulators today on issues including the government’s life sciences strategy and Brexit’s impact on the industry.
Big Pharma
UK life sciences receives £160m government funding
30 August 2017   The UK government has committed £160 million ($280.2 million) in funding to the life sciences after a review of the industry.

More on this story

Big Pharma
House of Lords hears evidence on life sciences and Brexit
17 October 2017   The House of Lords is hearing from companies and regulators today on issues including the government’s life sciences strategy and Brexit’s impact on the industry.
Big Pharma
UK life sciences receives £160m government funding
30 August 2017   The UK government has committed £160 million ($280.2 million) in funding to the life sciences after a review of the industry.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB